Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L
Year: 2022
Type: article
Source: Lung Cancer
Authors: Sanjay Popat, Hye Ryun Kim, Myung-Ju Ahn, James Yang, Ji-Youn Han, Maximilian Hochmair, Ki Hyeong Lee, Angelo Delmonte, Maria Garcia Campelo, Dong-Wan Kim, Frank Griesinger, Enriqueta Felip, Raffaele Califano, Alexander Spira, Scott Gettinger, Marcello Tiseo, Huamao Lin, Yuyin Liu, Florin Vranceanu, D Camidge
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4211175981